What is the role of adjuvant therapy after liver transplantation for hepatocellular carcinoma?
β Scribed by Christophe Duvoux; Tetsuya Kiuchi; Bernhard Pestalozzi; Ronald Busuttil; Rebecca Miksad
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 198 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.22367
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The recurrence of hepatocellular carcinoma (HCC) is a major cause of mortality for patients transplanted with HCC. There currently exists no standard method for identifying those patients with a high risk for recurrence. Identification of factors leading to recurrence is necessary to develop an effi
The purposes of cancer staging are (1) to accurately predict a patient's prognosis and (2) to determine the appropriate interventions. Hepatocellular carcinoma (HCC) is somewhat unique: it usually affects patients with underlying liver disease, and both tumor burden and liver function need to be car
Huo and colleagues 1 appropriately note that the low complete response rate to radiofrequency ablation (RFA) in our study contrasts markedly with much of the published literature. Their surprise regarding this finding originates from the commonly held belief that RFA effectively ablates hepatocellul